Charles River Laboratories | CRL - PE Price to Earnings

Stock Price
171.23
Daily Change
1.43 0.84%
Monthly
7.21%
Yearly
48.79%
Q2 Forecast
166.17

Charles River Laboratories reported 43.58 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Agilent 25.04 2.13 Dec/2025
Align Technology 19.74 1.58 Dec/2025
Bio-Rad Laboratories 16.42 17.1 Sep/2025
Bruker 81.36 60.11 Dec/2025
Cardinal Health 24.53 4.66 Dec/2025
Charles River Laboratories 43.58 0.86 Dec/2025
Cigna 10.56 0.76 Dec/2025
CVS Health 14.39 2.15 Dec/2025
Danaher 29.29 10.39 Mar/2026
Dentsply International 29.99 15.81 Dec/2025
Elevance Health 12.4 0.98 Mar/2026
Galapagos 3.14 50.78 Dec/2025
Humana 26.05 7.23 Dec/2025
Illumina 30.38 15.53 Dec/2025
Incyte 14.84 2.79 Dec/2025
Intrexon 7.54 221.44 Dec/2021
IQVIA Holdings 26.59 2.03 Dec/2025
Laboratory Of America 20.86 10.79 Dec/2025
Lonza 34.34 2.58 Dec/2025
McKesson 23.85 0.07 Dec/2025
Merck 20.56 7.18 Dec/2025
Mettler Toledo International 32.41 2.38 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Quest Diagnostics 22.4 2.63 Mar/2026
Revvity 49.87 16.58 Dec/2025
Thermo Fisher Scientific 27.71 3.29 Mar/2026
United Therapeutics 17.32 1.62 Dec/2025
UnitedHealth 15.29 4.5 Mar/2026
Veradigm 11.15 4.63 Sep/2022
Waters 35.29 8.46 Dec/2025
West Pharmaceutical Services 31.99 5.76 Mar/2026